FDA approves second Moderna vaccine

The U.S. Food and Drug Administration approved a second COVID-19 vaccine on Monday. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older. According to Moderna, Spikevax has the same formulation as the EUA Moderna COVID-19 Vaccine and is administere...